Literature DB >> 1852997

[Hypoglycemia induced by cibenzoline in the elderly].

C Houdent1, C Noblet, C Vandoren, H Levesque, C Morin, N Moore, H Courtois, L M Wolf.   

Abstract

Hypoglycaemia induced by class IA antiarrhythmic agents has been described. A case of cibenzoline-induced hypoglycaemia with favourable outcome is reported. The patient's age (84 years), increased renal impairment and malnutrition acted as facilitating factors. Blood insulin levels were normal in both absolute and relative values. Therapeutic overdosage in relation to age and renal function has been found in 20 out of 24 cases published or recorded by the French pharmacovigilance system. The mechanism of this hypoglycaemia is uncertain; absolute or relative hyperinsulinism has been detected in only 5 out of 14 controlled cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852997     DOI: 10.1016/s0248-8663(05)81379-7

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  5 in total

1.  A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.

Authors:  Fleur Grégoire; Antoine Pariente; Annie Fourrier-Reglat; Françoise Haramburu; Bernard Bégaud; Nicholas Moore
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

2.  Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline.

Authors:  A Ishida-Takahashi; M Horie; Y Tsuura; H Ishida; T Ai; S Sasayama
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

4.  Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic beta-cells.

Authors:  M Kakei; M Nakazaki; T Kamisaki; I Nagayama; Y Fukamachi; H Tanaka
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 5.  Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.

Authors:  D W Harron; R N Brogden; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.